LGCYHIGH SIGNALFINANCIAL10-K

LGCY reported substantially higher revenue and operating income alongside a near-doubling of total assets and cash position, indicating significant business expansion.

The company's financial profile has meaningfully expanded with revenue growing nearly 40% while operating income grew substantially, suggesting improving operational leverage. The near-doubling of assets and cash position indicates either major capital raising activities, acquisitions, or exceptional cash generation that has fundamentally strengthened the balance sheet.

Comparing 2025-09-25 vs 2024-10-01View on EDGAR →
FINANCIAL ANALYSIS

LGCY demonstrated strong financial growth with revenue increasing 39.5% to $64.2M and net income growing 47.3% to $7.5M, while operating income expanded substantially. The balance sheet roughly doubled in size with total assets reaching $69.2M and cash nearly doubling to $20.3M, while stockholders' equity increased 83.1% to $41.0M. This comprehensive financial expansion suggests successful business scaling, though capital expenditures also roughly doubled to $844K as the company invested in growth infrastructure.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
+99.3%
$424K→$844K

Capital expenditure jumped 99.3% — major investment cycle underway; assess returns on deployment.

Total Assets
Balance Sheet
+96.8%
$35.2M→$69.2M

Asset base grew 96.8% — expansion through organic growth, acquisitions, or capital deployment.

Cash & Equivalents
Balance Sheet
+95.8%
$10.4M→$20.3M

Cash position surged 95.8% — strong cash generation or capital raise providing significant financial cushion.

Total Debt
Balance Sheet
+88%
$748K→$1.4M

Debt increased 88% — substantial leverage increase; assess whether deployed for growth or covering losses.

Stockholders Equity
Balance Sheet
+83.1%
$22.4M→$41.0M

Equity base grew 83.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Operating Income
P&L
+60.6%
$6.2M→$10.0M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Current Assets
Balance Sheet
+50.7%
$24.6M→$37.1M

Current assets grew 50.7% — improving short-term liquidity or inventory/receivables build.

Net Income
P&L
+47.3%
$5.1M→$7.5M

Net income grew 47.3% — bottom-line growth signals improving overall business health.

Revenue
P&L
+39.5%
$46.0M→$64.2M

Strong top-line growth of 39.5% — accelerating demand or successful expansion into new markets.

Current Liabilities
Balance Sheet
+31.7%
$10.5M→$13.8M

Current liabilities surged 31.7% — significant near-term obligations; verify ability to meet short-term debt.

LANGUAGE CHANGES
NEW — 2025-09-25
PRIOR — 2024-10-01
ADDED
Number of common shares outstanding as of September 22, 2025 was 12,561,684 .
Securities and Exchange Commission within 120 days of the Registrant s fiscal year ended June 30, 2025.
Risks Related to the Highly Regulated Field in Which We Operate Current and future federal and state statutes, or regulations promulgated by ED or other federal, state, or accrediting agencies, could materially and adversely affect our operations, business, results of operations, financial condition and cash flows.
The OBBBA (defined below) provisions related to low earning outcome programs and ED s gainful employment regulation may limit the programs we can offer students and increase our cost of operations.
If ED denies, or significantly conditions, recertification of any of our institutions to participate in Title IV Programs, that institution could not conduct its business as it is currently conducted and it could have an adverse effect on our business and results of operations.
If our students access to financial aid from state sources, from federal sources other than the Title IV Programs, or from alternative loan programs is lost or reduced, due to changes in legal requirements or funding availability or due to noncompliance with legal requirements, it could impact our results of operations.
Our institutions could be subject to liabilities, sanctions, or loss of eligibility if they violate statutory provisions of Title IV of the Higher Education Act of 1965, as amended, and related ED regulations and guidance.
Risks Related to Our Business Our financial performance depends on the level of student enrollment in our institutions.
Risks Related to Our Common Stock We are subject to the rules and regulation of the NYSE American and are required to comply with certain continued exchange listing standards and requirements or be subject to delisting.
Market and economic conditions may negatively impact our business, financial condition, and share price.
REMOVED
Number of common shares outstanding as of September 27, 2024 was 11,867,162 .
Regulations promulgated by ED or other agencies could materially and adversely affect our operations, business, results of operations, financial condition and cash flows.
ED s gainful employment regulation may limit the programs we can offer students and increase our cost of operations.
If ED denies, or significantly conditions, recertification of any of our institutions to participate in Title IV Programs, that institution could not conduct its business as it is currently conducted.
If our students access to financial aid from state sources, from federal sources other than the Title IV Programs, or from alternative loan programs is lost or reduced, it could impact our results of operations.
Our financial performance depends on the level of student enrollment in our institutions.
An active trading market for our common stock may not develop, and you may not be able to sell your common stock at or above the initial public offering price.
BUSINESS Overview We provide career-focused, post-secondary education services to students at all stages of adult life, from recent high school graduates to working parents, through our accredited academic institutions: High Desert Medical College, which we acquired in July 2010, Central Coast College, which we acquired in January 2019, and Integrity College of Health.
HDMC offers UT, VN, VN Associate of Applied Science degree program, Associate Degree of Nursing, nursing assistant, MRI Associate of Applied Science, cardiac sonography, pharmacy technician, dental assisting, clinical medical assisting, medical administrative assisting programs, medical billing and coding, veterinary assistant, phlebotomy technician avocational, nursing assistant avocational, and UT Associate of Applied Science degree programs.
HDMC also plans to offer an emergency medical technician (EMT) program beginning in October 2024 and is in the process of obtaining approvals for the program (for which HDMC is not planning to apply for ED approval to make Title IV Program funds available for students who enroll in the program).
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →